Exploring Deep Brain Stimulation & Focused Ultrasound for Parkinson’s Disease

Insights from Dr. Ihtsham Ul Haq and Tom Liodice on APDA’s Dr. Gilbert Hosts Deep brain stimulation (DBS) and...see more focused ultrasound (FUS) are two medical procedures that may be considered for certain people with PD to help alleviate symptoms. On a recent episode of APDA’s Dr. Gilbert Hosts, I spoke with Dr. Ihtsham Ul Haq, a movement […]

Read More

2023 Update: New Parkinson’s Disease Treatments in the Clinical Trial Pipeline

New Parkinson’s Medication on the Horizon The development of potential new medications for Parkinson’s disease (PD) medications remains very...see more active, with multiple new medications in various stages of research development that are aiming to treat and slow down PD. In past blogs, we have reviewed the various mechanisms of action that are being studied to […]

Read More

Improving Deep Brain Stimulation for Parkinson’s: An Interview with ADPA Researcher, Dr. Enrico Opri

A Closer Look: An Interview with Dr. Enrico Opri Our A Closer Look blog is designed to educate, inform, and inspire...see more you through a variety of topics and insights about Parkinson’s disease (PD). One way we do that is through our Interview with APDA Researchers series within this blog so you can get a closer look at some of […]

Read More

Light Therapy for Parkinson’s Disease

Light therapy and Parkinson’s disease Light therapy, or the use of light as a treatment for disease, is being...see more investigated in many neurologic conditions including as a treatment for some of the symptoms of Parkinson’s disease (PD). Light therapy encompasses a large category of treatments involving different types of light and delivery systems. More research […]

Read More

Cognitive Rehabilitation for Parkinson’s Disease

Cognitive Changes are Common in Parkinson’s Cognitive difficulties are a common non-motor symptom in Parkinson’s disease (PD) and can...see more affect many facets of everyday life. Executive function, or the ability to plan and organize multi-step activities can specifically be affected in PD. Visuo-spatial skills, which allow a person to navigate in three dimensions, estimating distances […]

Read More

The Future of Parkinson’s Disease Treatments – What’s New?

New Parkinson’s Disease Treatments in the Pipeline The pipeline for new Parkinson’s disease (PD) medications is very crowded, with...see more multiple new medications in various stages of research development that are targeting neuroprotection, as well as motor and non-motor symptoms. In several past blogs we have reviewed many strategies currently being tested for PD, which you […]

Read More

Meet Dr. Abby Olsen, an APDA-Funded Researcher Studying Parkinson’s Genes in Glial “Helper” Cells

Q&A with Dr. Abby Olsen on Glial Cells in Parkinson’s Disease Treatment A conversation about genes in glial helper...see more cells (and fruit flies!) Our A Closer Look blog is designed to educate, inform, and inspire you through a variety of topics and insights about Parkinson’s disease (PD). One way we do that is through our Interview with APDA […]

Read More

Wearable devices that suppress Parkinson’s disease tremor

Non-Invasive Devices to Suppress Tremors For some people with Parkinson’s disease (PD), medication doses treat their tremor very well....see more However, for others, medication doses are clearly effective for symptoms of slowness and stiffness, but they are ineffective for their tremor. In these cases, deep brain stimulation (DBS) or focused ultrasound may be suggested to help […]

Read More

New Treatments for Parkinson’s Disease

Exploring seven recently approved Parkinson’s treatments Remarkably, in the last five years, seven new medications have been approved for...see more the treatment of the motor symptoms of Parkinson’s disease (PD), with two approved in 2020. That’s exciting progress! And while it is great to have so many choices, the various options can be confusing — so […]

Read More

The Future of Parkinson’s Disease Treatments – UPDATE

The Parkinson’s disease (PD) research community is extremely eager to find a medication that is disease modifying or neuroprotective (meaning it...see more protects the nerve cells from damage or degeneration). There have been many attempts over the past number of years to demonstrate through clinical trials that particular compounds have neuroprotective effects but to date, these attempts have […]

Read More